期刊文献+

2-巯基-4-(4-吡啶基)噻唑的合成及其与头孢母环对接工艺优化

Synthesis of(2)-mercapto-4-(4-pyridyl)thiazole and its optimization of docking process with cephalosporin ring
下载PDF
导出
摘要 以4-乙酰吡啶为主要原料,经过溴化、硫化、环合、碱性水解、脱酸等一系列反应,制得头孢洛林酯三位侧链2-巯基-4-(4-吡啶基)噻唑,总收率37.47%。以碱活化巯基生成4-(4-吡啶基)-1,3-噻唑-2-硫醇钠,并与3位完成活化的3-羟基头孢对接,制得7β-苯乙酰氨基-3-(4-吡啶基-2-噻唑巯基)-3-头孢烯-4-羧酸二苯甲基酯(BPMCC)。通过MS和1H NMR对目标产物及各步反应中间体的结构进行了表征。结果表明,加入洗气装置可将二硫代氨基甲酸铵的产率提升到89.2%;改进了2-巯基-4-(4-吡啶基)噻唑氢溴酸盐环合工艺,确定最佳反应温度为0℃,最佳溶剂为无水乙醇、乙腈混合溶液,最佳投料比n(4-溴乙酰吡啶氢溴酸盐)∶n(二硫代氨基甲酸)=1∶1.1;确定了2-巯基-4-(4-吡啶基)噻唑从反应体系中析出的最佳pH为6.8;确定了宜采用分步法生产7β-苯乙酰氨基-3-(4-吡啶基-2-噻唑巯基)-3-头孢烯-4-羧酸二苯甲基酯。 The main chain of 4-acetylpyridine was subjected to a series of reactions such as bromination,sulfurization,cyclization,alkaline hydrolysis and deacidification to obtain the three-position side chain of ceftarolinepozhe-(2)-mercapto-4-(4-pyridyl)thiazole,the total yield was 37.47%.The base was activated to form a 4-(4-pyridyl)-1,3-thiazole-2-thiolate sodium,and was docked with the 3-activated 3-hydroxycephalosporin to obtain 7β-phenylacetamido-3-(4-pyridinyl-2-thiazolyl)-3-cephem-4-carboxylic acid benzhydryl ester(BPMCC).The structure of the target product and the reaction intermediate of each step was characterized by MS and 1 H NMR.The results were as follows:the addition of a scrubber increased the yield of ammonium dithiocarbamate to 89.2%;improved the(2)-mercapto-4-(4-pyridyl)thiazole hydrobromide ring closure process to determine the best reaction temperature was 0℃,the optimum solvent was the mixed solution of anhydrous ethanol and acetonitrile;the optimal raw material ratio were determined:n(4-bromoacetylpyridine hydrobromide)∶n(dithiocarbamic acid)=1∶1.1;The optimum pH of 2-mercapto-4-(4-pyridyl)thiazole precipitated from the reaction system was 6.8;The 7β-phenylacetamido-3-(4-pyridyl-2-thiazolyl)-3-cephem-4-carboxylic acid benzhydryl ester was produced by a stepwise method.
作者 曹辉 薛峰 董乾乾 居沈贵 CAO Hui;XUE Feng;DONG Qian-qian;JU Shen-gui(College of Chemical Engineering,Nanjing Tech University,Nanjing 211816,China)
出处 《应用化工》 CAS CSCD 北大核心 2020年第6期1339-1343,共5页 Applied Chemical Industry
基金 国家自然科学基金(U1407122)。
关键词 4-乙酰吡啶 环合 3-羟基头孢 对接 活化 4-acetylpyridine cyclization 3-hydroxycephalosporin docking activation
  • 相关文献

参考文献4

二级参考文献76

  • 1ISHIKAWA T, MATSUNAGA N, TAWADA H, et al. TAK- 599, a novel N-phosphono type prodmg of anti-MRSA cepha- losporin T-91825 : synthesis, physicochemical and pharmaco- logical properties [ J ]. Bioorg Med Chem, 2003,11 ( 11 ) : 2427 - 2437.
  • 2ISHIKAWA T, HASHIGUCHI S, IIZAWA Y. Phosphono- cephem compound :WO,0214333 [ P]. 2002 - 02 - 21.
  • 3STEED M E, RYBAK M J. Ceftaroline:a new cephalosporin with activity against resistant gram-positive pathogens [ J ]. Pharmacotherapy,2010,30(4) :375 -389.
  • 4ZHANEL G G, SNJEZEK G, SCHWEIEER F. Ceftaroline: a novel broad-spectrum cephalosporin with activity against meti-cillin-resistant Staphylococcus aureus [J]. Drugs, 2009, 69 (7) :809 -831.
  • 5Livermore DM.Has the era of untreatable infections arrived[J]?J Antimicrob Chemother,2009,64(Suppl 1):i29-i36.
  • 6Rhomberg PR,Jones RN.Summary trends for the meropenem yearly susceptibility test information collection program:a 10-year experience in the United States(1999-2008)[J].Diagn Microbiol Infect Dis,2009,65(4):414-426.
  • 7Saravolatz LD,Stein GE,Johnson LB.Telavancin:a novel lipoglycopeptide[J].Clin Infect Dis,2009,49(12):1908-1914.
  • 8Saravolatz LD,Stein GE,Johnson LB.Ceftaroline:a novel cephalosporin with activity against methicillin-resistant Staphylococcus aureus[J].Clin Infect Dis,2011,52(9):1156-1163.
  • 9Sullivan KM,Spooner LM.Fidaxomicin:a macrocyclic antibiotic for the management of Clostridium difficile infection[J].Ann Pharmacother,2010,44(2):352-359.
  • 10da Silva LM,Nunes Salgado HR.Tigecycline:a review of properties,applications,and analytical methods[J].Ther Drug Monit,2010,32(3):282-288.

共引文献75

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部